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Abstract 
Purpose: Choline-containing dietary phospholipids, including phosphatidylcholine (PC), may 
function as anti-inflammatory substances, but the mechanism remains largely unknown. We 
investigated the effects of L-alpha-glycerylphosphorylcholine (GPC), a deacylated PC 
derivative, in a rodent model of small intestinal ischaemia-reperfusion (IR) injury.  
Methods: Anaesthetized Sprague-Dawley rats were divided into control, mesenteric IR (45 
min mesenteric artery occlusion, followed by 180 min reperfusion), IR with GPC 
pretreatment (16.56 mg kg-1 GPC i.v., 5 min prior to ischaemia) or IR with GPC post-
treatment (16.56 mg kg-1 GPC i.v., 5 min prior to reperfusion) groups. Macrohaemodynamics 
and microhaemodynamic parameters were measured; intestinal inflammatory markers 
(xanthine oxidoreductase activity, superoxide and nitrotyrosine levels) and liver ATP contents 
were determined.  
Results: The IR challenge reduced the intestinal intramural red blood cell velocity, increased 
the mesenteric vascular resistance, the tissue xanthine oxidoreductase activity, the superoxide 
production and the nitrotyrosine levels, and the ATP content of the liver was decreased. 
Exogenous GPC attenuated the macro- and microcirculatory dysfunction and provided 
significant protection against the radical production resulting from the IR stress. The GPC 
pretreatment alleviated the hepatic ATP depletion, the reductions in the mean arterial pressure 
and superior mesenteric artery flow, and similarly to the post-treatments with GPC, also 
decreased the xanthine oxidoreductase activity, the intestinal superoxide production, the 
nitrotyrosine level, and normalized the microcirculatory dysfunction.  
Conclusions: These data demonstrate the effectiveness of GPC therapies, and provide indirect 
evidence that the anti-inflammatory effects of PC could be linked to a reaction involving the 
polar part of the molecule. 
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Introduction 
Ischaemia-reperfusion (IR) contributes to the pathology of many human diseases [1], 
and experimental IR has become a widely-used technique for the investigation of 
standardized, antigen-independent inflammation. Acute IR models are typically characterized 
by the release of soluble inflammatory mediators, cellular and subcellular functional changes 
including the activation of polymorphonuclear (PMN) leukocytes and the production of, 
among others, reactive oxygen and nitrogen species (ROS and RNS, respectively) [2, 3]. Anti-
inflammatory therapy mainly focuses on providing protection against the harmful 
consequences of PMN reactions [4] and on the oxidative and nitrosative stress responses to 
mitigate the damage to the affected tissues. 
The nutritional status is generally considered as an important factor in the 
development of surgical complications, and dietary regimens hold some promise of limiting 
inflammation. Phosphatidylcholine (PC) is an essential component of biomembranes and 
endogenous surface-coating substances, and it is well established that the main elements of 
IR-induced tissue injuries include lipid peroxidation and the loss of membrane-forming 
phosholipid bilayers [5]. Likewise, it has been shown that a reduced PC content of the 
intestinal mucus plays significant roles in the development of inflammatory bowel diseases 
[6]. Interestingly, a number of data suggest that choline-containing phospholipids, including 
PC, may function as anti-inflammatory substances under highly oxidizing IR conditions. 
Several studies have indicated that exogenous PC inhibits leukocyte accumulation [7, 8] and 
the generation of inflammatory cytokines [9], and dietary PC administration has been 
demonstrated to provide protection against experimental neuroinflammation, arthritis and 
pleurisy [8, 10, 11] in rodents. Nevertheless, the specific mechanism of action of PC is still 
not known with certainty, and the question arises as to which of the moieties in the PC 
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molecule are of critical significance in the reduction of the leukocyte responses and pro-
inflammatory signal production. 
The PC molecule is composed of a choline head group and glycerophosphoric acid, 
with a variety of saturated and unsaturated fatty acids; given their potent bioactions, lipids 
may be pro-inflammatory or deactivate inflammatory pathway signalling in vivo [12, 13] and 
can possiby influence tissue damage. On the other hand, emulsions containing deacylated 
phospholipid derivatives do not induce endoplasmic reticulum stress or the activation of 
inflammatory pathway signalling [13]. L-alpha-glycerylphosphorylcholine (GPC) is a water-
soluble, deacylated PC intermediate which may be hydrolysed to choline and can possibly be 
used for the resynthesis of PC [14]. Interestingly, significantly lower concentrations of hepatic 
GPC have been reported after experimental haemorrhagic shock, a prototype of systemic IR, 
with recovery to the baseline only 24 h later [15].  
All these lines of research converge in suggesting that GPC would be efficacious in 
influencing the inflammatory response. We therefore assessed the biochemical and circulatory 
effects of exogenous GPC treatment in a rat model of mesenteric IR-induced intestinal 
inflammation, and postulated that the results can provide indirect in vivo data towards an 
understanding of the mechanism of anti-inflammatory action of PC therapy. 
 
Methods and Materials 
Animals  
The experiments were performed on 32 adult male Sprague-Dawley rats (250-300 g) 
housed in plastic cages in a thermoneutral environment (21±2 °C) with a 12-h dark-light 
cycle. Food and water were provided ad libitum. The experimental protocol was approved by 
the Ethical Committee for the Protection of Animals in Scientific Research at the University 
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of Szeged and followed the National Institutes of Health (Bethesda, MD, USA) guidelines on 
the care and use of laboratory animals. 
Experimental protocol 
The animals were randomly allocated into four groups (n = 8 each): a control, sham-
operated group, a group that participated in intestinal IR, and groups that took part in IR with 
GPC pretreatment (GPC + IR) or in IR with GPC post-treatment (IR + GPC). The GPC (MW: 
257.2, Lipoid GmbH, Ludwigshafen, Germany) was administered intravenously (i.v.) in a 
dose of 16.56 mg kg-1 bw, as a 0.064 mM solution in 0.5 ml sterile saline. These dosage 
conditions were based on the data of previous investigations with PC; this dose was equimolar 
with the effective, anti-inflammatory dose of PC (MW: 785; 0.064 mM, 50 mg (kg bw)-1, i.v.) 
in rodents [16, 17]. The GPC pre- or post-treatment was applied once, either directly before 
the ischaemic period or immediately after the ischaemia, before the start of reperfusion.  
The animals were anaesthetized with sodium pentobarbital (50 mg (kg bw)-1, 
intraperitoneally) and placed in a supine position on a heating pad. Tracheostomy was 
performed to facilitate spontaneous breathing, and the right jugular vein was cannulated with 
polyethylene (PE50) tubing for central venous pressure (CVP) measurements and Ringer's 
lactate infusion (10 ml kg-1 h-1) during the experiments. The right common carotid artery was 
cannulated with PE50 tubing for mean arterial pressure (MAP) and heart rate (HR) 
measurements.  
After midline laparotomy, the animals in groups IR, GPC + IR and IR + GPC were 
subjected to 45 min ischaemia by occlusion of the superior mesenteric artery (SMA) with an 
atraumatic vascular clamp. 45 min after the start of the ischaemic insult, the vascular clamp 
was removed and the intestine was reperfused. The SMA blood flow was measured 
continuously with an ultrasonic flowmeter (Transonic Systems Inc., Ithaca, NY, U.S.A.) 
placed around the artery. The abdomen was temporary closed and the intestine was reperfused 
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for 180 min. In the sham-operated control group, the animals were treated in an identical 
manner except that they did not undergo clamping of the artery. 
After 180 min of reperfusion, tissue samples were taken from the liver to determine 
the ATP content, and biopsies were taken from the ileum to examine the tissue nitrotyrosine 
and superoxide (SOX) production and the xanthine oxidoreductase (XOR) activity.  
Haemodynamic measurements 
The MAP and SMA blood flow signals were monitored continuously and registered 
with a computerized data-acquisition system (SPELL Haemosys; Experimetria Ltd., 
Budapest, Hungary). The mesenteric vascular resistance (MVR) was calculated via the 
standard formula (MVR = (MAP - CVP) / SMA flow).  
Intravital video-microscopy  
The intravital orthogonal polarization spectral imaging technique (Cytoscan A/R, 
Cytometrics, PA, USA) was used for non-invasive visualization of the serosal 
microcirculation of the ileum 3-4 cm proximal from the coecum. This technique utilizes 
reflected polarized light at the wavelength of the isobestic point of oxy- and 
deoxyhaemoglobin (548 nm). As polarization is preserved in reflection, only photons 
scattered from a depth of 2–300 µm contribute to image formation. A 10 x objective was 
placed onto the serosal surface of the ileum, and microscopic images were recorded with an 
S-VHS video recorder 1 (Panasonic AG-TL 700, Panasonic, NJ, USA). Quantitative 
assessment of the microcirculatory parameters was performed off-line by frame-to-frame 
analysis of the videotaped images. The red blood cell velocity (RBCV, µm s -1) changes in the 
postcapillary venules were determined in three separate fields by means of a computer-
assisted image analysis system (IVM Pictron, Budapest, Hungary). All microcirculatory 
evaluations were performed by one investigator (E.T.).  
ATP measurement 
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The liver samples were cooled in liquid nitrogen, and stored at -70 oC until assays. The 
tissue was weighed, placed into a 3-fold volume of trichloroacetic acid (6% w/v), 
homogenized for 1 min, and centrifuged at 5000 g. After adjustment of the pH to 6.0 with 
saturated K2CO3 solution, the reaction mixtures were prepared by the addition of 100 µl of 
ATP assay mix (containing firefly luciferase, luciferin, MgSO4, EDTA, DTT and BSA in a 
Tricine buffer; Sigma-Aldrich GmbH, Munich, Germany) to 100 µl of 5-fold-diluted sample. 
The ATP determinations were based on the measurement of luciferase chemiluminescence, 
using a luminometer (LUMAT LB 9507, Berthold Technologies, GmbH, Bad Wilbad, 
Austria). The ATP levels were calculated with the aid of a standard ATP calibration curve 
(Sigma-Aldrich GmbH, Munich, Germany) and the data were referred to the sample weights.  
Intestinal SOX production 
The level of SOX production in freshly minced intestinal biopsy samples was assessed 
by the lucigenin-enhanced chemiluminescence assay of Ferdinandy et al. [18]. Briefly, 
approx. 25 mg of intestinal tissue was placed in 1 ml of Dulbecco’s solution (pH 7.4) 
containing 5 µM lucigenin. The manipulations were performed without external light 2 min 
after dark adaptation. Chemiluminescence was measured at room temperature in a liquid 
scintillation counter by using a single active photomultiplier positioned in out-of-coincidence 
mode, in the presence or absence of the SOX scavenger nitroblue tetrazolium (NBT; 20 µl). 
NBT-inhibited chemiluminescence was considered an index of intestinal SOX generation. 
Xanthine oxidoreductase (XOR) activity 
Colon and ileum tissue samples were kept on ice until homogenized in phosphate 
buffer (pH = 7.4) containing 50 mM Tris-HCl (Reanal, Budapest, Hungary), 0.1 mM EDTA, 
0.5 mM dithiotreitol, 1 mM phenylmethylsulfonyl fluoride, 10 µg ml-1 soybean trypsin 
inhibitor and 10 µg ml-1 leupeptin. The homogenate was loaded into centrifugal concentrator 
tubes and examined by fluorometric kinetic assay on the basis of the conversion of pterine to 
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isoxanthopterine in the presence (total XOR) or absence (xanthine oxidase activity) of the 
electron acceptor methylene blue [19]. 
Intestinal nitrotyrosine level 
Free nitrotyrosine, as a marker of peroxynitrite generation, was measured by enzyme-
linked immunosorbent assay (Cayman Chemical; Ann Arbor, MI, USA). Small intestinal 
tissue samples were homogenized and centrifuged at 15000 g. The supernatants were 
collected and incubated overnight with anti-nitrotyrosine rabbit IgG and nitrotyrosine 
acetylcholinesterase tracer in precoated (mouse anti-rabbit IgG) microplates, followed by 
development with Ellman’s reagent. Nitrotyrosine content was normalized to the protein 
content of the small intestinal homogenate and expressed in ng mg-1. 
Statistical analysis 
Data analysis was performed with a statistical software package (SigmaStat for 
Windows, Jandel Scientific, Erkrath, Germany). Due to the non-Gaussian data distribution, 
non-parametric methods were used. Friedman repeated measures analysis of variance on 
ranks was applied within groups. Time-dependent differences from the baseline for each 
group were assessed by Dunn’s method. Differences between groups were analysed with 
Kruskal-Wallis one-way analysis of variance on ranks, followed by Dunn’s method for 
pairwise multiple comparison. In the Figures and Results, median values (M), and 75th (p75) 
and 25th (p25) percentiles are given. Values of p<0.05 were considered statistically 
significant. *p < 0.05 relative to the baseline value (within groups), #p < 0.05 relative to the IR 
group, xp < 0.05 relative to the sham-operated control group and @p < 0.05 relative to the 
GPC + IR group. 
 
Results 
Haemodynamics 
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There were no significant changes in the haemodynamic parameters during the 
experiment as compared with the baseline values in the sham-operated group. A decreasing 
tendency in MAP was found in all IR groups as compared wirh the sham-operated group 
(M:103; p25:97.5; p75:115) and it remained at this low level untill the end of the experiment 
(IR group: M:88; p25:82; p75:94; IR + GPC: M:73; p25:67; p75:85). MAP was elevated in 
the GPC + IR group (M:93; p25:85; p75:101) (Figure 1). There was no statistically significant 
difference in HR between the different groups during the experiment (data not shown). 
In the IR group (M:19.6; p25:13.7; p75:26.4), there was a significant elevation in 
MVR relative to the control value (M:5.8; p25:4.4; p75:6.7) up to 225 min of the reperfusion. 
This parameter exhibited a pronounced reduction in the GPC + IR group (M:9.7; p25:8.1; 
p75:12.9) and a tendency to diminish in the IR + GPC group (M:10.3; p25:9.2; p75:11.6) 
(Figure 2).  
After the ischaemia, the SMA flow was significantly reduced in the IR group (M:4.08; 
p25:3.24; p75:5.4) relative to the sham-operated group (M:14.52; p25:11.7; p75:17.99), but 
this difference was not observed in the IR + GPC group (M:6.67; p25:5.8; p75:7.56). 
Moreover, there was an unequivocal tendency for this parameter to increase in the GPC + IR 
group (M:7.53; p25:5.65; p75:9.14) as compared with the IR group (Figure 3).  
Microcirculation 
The RBCV of the serosa was examined as a quantitative marker of the ileal 
microcirculatory condition. The RBCV was significantly decreased in the IR group (M:660; 
p25:469; p75:706) as compared with the sham-operated group (M:939; p25:737; p75:1046). 
IR + GPC (M:1228; p25:1153; p75:1256) caused a significant elevation and normalized the 
IR-induced reduction in RBCV by 15 min of the reperfusion period. An increasing tendency 
was seen in the GPC + IR group (M:966; p25:774; p75:1280) (Figure 4). 
Biochemical parameters 
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Superoxide production in the small intestine 
The ROS-producing capacity of the small intestinal biopsy samples did not change in 
the sham-operated animals. By 15 min of reperfusion, there was a significant enhancement in 
the IR group (M:2019.4; p25:1814.5; p75:2349.3) relative to the baseline value and also the 
sham-operated group (M:1182.2; p25:1046.6; p75:1340). Both GPC + IR (M:958; p25:856; 
p75:1476) and IR + GPC treatment (M:1228; p25:839; p75:1568) resulted in an appreciable 
reduction in the SOX level as compared with the IR group. This tendency was maintained 
until the end of the experiments (Figure 5). 
XOR activity in the small intestine 
XOR is activated during IR and produces a considerable amount of SOX. At the end 
of the experiments, we observed a significantly higher XOR activity in the IR animals 
(M:78.6; p25:67.7; p75:80.2) than in the sham-operated ones (M:41.8; p25:27.3; p75:55.9). 
The XOR activity was also significantly elevated in the GPC + IR group (M:78; p25:72; 
p75:84). In contrast, the XOR activity was significantly lower in the IR + GPC group (M:19; 
p25:14; p75:21) than in either the IR or the GPC + IR groups. The IR + GPC treatment 
proved highly effective against ROS-producing mechanisms (Figure 6). 
Tissue nitrotyrosine level 
Nitrotyrosine formation is a marker of nitrosative stress within the tissues, and 
correlates with peroxynitrite production. IR resulted in a significant increase in nitrotyrosine 
level (M:2.6; p25:2.1; p75:3.1) relative to the control group (M:1.4; p25:1.3; p75:1.8) at the 
end of the experiment. In both the GPC + IR (M:1.3; p25:1.05; p75:1.6) and the IR + GPC 
group (M:1.5; p25:1.2; p75:1.57), however, this increase did not take place, and the 
nitrotyrosine content remained at the control level (Figure 7). 
ATP level in liver samples 
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In consequence of the outstanding generation of ROS in the mitochondria, at the end 
of the reperfusion the ATP level in the IR group (M:1206.7; p25:1093.5; p75:1521) was 
significantly lower than in the sham-operated group (M:2025; p25:1775; p75:2232.5). As 
compared with the IR group, there was a tendency to an elevation in the GPC + IR group 
(M:1690.8; p25:1410.3; p75:1991.2) and a significantly higher ATP level in the IR + GPC 
group (M:1977.4; p25:1802.5; p75:2133.9). No difference was detected between the levels in 
the IR + GPC and sham-operated groups (Figure 8). 
 
Discussion 
The suppression of inflammation is of importance in the control of a variety of human 
pathologies, and the main goal of this study was to design and test potential therapies with 
which to prevent or influence the short-term inflammatory consequences of an acute 
ischaemic challenge. During ischaemia, the lack of electron-acceptor molecules causes a 
redox imbalance [20], and the ensuing reoxygenization period is accompanied by harmful 
signs of inflammatory activation. This phenomenon results in local structural damage and 
circulatory deficiences, and also leads to a great abundance of inflammatory mediators that 
might cause distant or multiorgan failures [21].  
In this study, intestinal IR decreased the MAP, the SMA flow and the intramural 
RBCV, and increased the MVR significantly. At the same time, the SOX, XOR and 
nitrotyrosine levels were elevated significantly in the small intestine, while the level of ATP 
in the liver was reduced. Overall, these data furnish evidence concerning the evolution of 
hypoxia/reoxygenation-induced, antigen-independent inflammation. 
The results also demonstrate that GPC treatment stabilizes the RBCV in the intestinal 
wall and the macrocirculation is also normalized. GPC administration exerted pronounced 
effects on the inflammatory process by lowering SOX production and the activity of XOR, a 
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prototype of ROS-producing enzymes. ROS are generated in the inflamed mucosa mainly by 
the mitochondria, XOR, activated phagocytic PMN leukocytes via the NADPH oxidase 
system and uncoupled endothelial nitric oxide synthase (NOS). During ischaemia, the 
synthesis of vasodilator NO is suppressed due to the absence of the required co-factors, while 
at the beginning of reoxygenization a number of SOX-producing enzymes, including XOR, 
become active, leading to peroxynitrite production [22]. The net result of these reactions is the 
enhanced effect of vasoconstrictor mediators. Our results clearly demonstrate the role of 
nitrosative stress and the effectiveness of GPC in decreasing nitrotyrosine formation. The data 
additionally indicate that GPC treatment moderates the vasoconstrictive effects of IR. In this 
regard, not only the macrocirculation, but also the microcirculatory changes in the small 
intestine are influenced. Practically speaking, we gained information on the intramural 
RBCV; significantly reduced values were found in the IR group. Due to the occlusion of a 
main perfusing artery, the tissue microcirculation was impaired and recovery took a longer 
time after the reestablishment of the blood flow. In contrast, the microperfusion was 
significantly improved in the GPC-treated animals. 
Further, the ATP level of the liver was significantly decreased in the sham-operated 
animals by the end of the reperfusion, and a tendency for ATP production to increase was 
seen in GPC-treated animals. These findings may be linked to the membrane-conserving 
effect of GPC under oxido-reductive stress conditions. A continuing lack of oxygen will cause 
reductive stress with abnormally elevated mitochondrial NADH/NAD+ ratio and the collapse 
of ionic homeostasis, leading to dissipation of the transmembrane potential. During 
reoxygenation the components of the mitochondrial electron transport chain (METC) in the 
inner membrane are main targets of ROS and RNS [23]. If prolonged, IR attacks lead to the 
otherwise reversible damage of the METC becoming irreversible, and functionless 
membranes and embedded proteins cannot synthesize ATP. Nevertheless, the METC- or 
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membrane-protective action of GPC, including the inhibition of mitochondrial ROS or RNS 
formation, demands further, in-depth investigations. 
Choline-containing phospholipids in mammals are critically involved in maintaining 
the structural integrity and the signalling functions of cellular membranes. PC is a major 
source of the second messenger diacylglycerol, phosphatidic acid, lysophosphatidic acid and 
arachidonic acid, which can be further metabolized to other signalling molecules. The main 
pathways for PC-mediated hydrolysis occur via phospholipases D, which produce choline and 
phosphatidic acid, and phospholipases A1 and A2, which generate free fatty acids and 
glycerol-phosphocholine [24]. The subsequent hydrolysis of glycerol-phosphocholine into 
glycerol 3-phosphate and choline is catalysed by a phosphodiesterase. 
Our previous studies and other investigations have characterized the anti-inflammatory 
properties of PC in detail [9, 11, 16, 25, 26, 27]. In this line it has been shown that PC 
treatment can reduce reperfusion-caused damage and increase the tolerance to hypoxia [16]. 
Other investigators have demonstrated that PC is capable of moderating the SOX production 
in PMN leukocytes, thereby inhibiting the activated inflammatory reaction [28, 29]. In 
another study, the degree of ATP depletion after IR was markedly improved by PC treatment, 
and the activity of leukocytes and the levels of pro-inflammatory mediator TNF-α generation 
and inducible NOS expression were reduced [11, 25]. 
The mechanism of action of GPC in IR-induced inflammatory changes is still not fully 
understood, and several possibilities should be taken into account. In the present study, GPC 
administration resulted in identical biological effects to those previously observed in similar 
in vivo models and PC therapy involving an equimolar dosage [16, 17]. This demonstrates 
indirectly that PC-derived lipids do not participate in this action, and the data suggest that the 
active component is the choline head group. In this regard, GPC may possibly possess a 
membrane-protective effect, promoting regenerative processes or conserving the double-lipid 
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layer, thereby preserving the original form and function of the cells. Indeed, previous studies 
have revealed that GPC has a special role in neurodegenerative processes [30]. It was 
previously shown that GPC can ameliorate the neural function after traumatic injuries [30, 
31], acute ischaemic stroke and Alzheimer’s disease [30, 32]. These findings tend to confirm 
the presumed precursor nature of GPC for the neurotransmitter acetylcholine, but also point to 
an effect on the re-synthesis of cell membrane lipid molecules such as PC. 
The stimulation of the α7 subunit of the nicotinic acetylcholine receptors (α7 nAChRs) 
could also contribute to the beneficial effects of GPC. Choline is a full agonist of α7 nAChRs 
[33], and it has been shown that dietary supplementation with choline results in selective 
increases in the density of α7 nAChRs in multiple brain regions [34]. The action of choline as 
a direct-acting α7 nAChR agonist may improve the cognitive outcome as this receptor is 
expressed at high levels in the rodent hippocampus [35, 36]. Nevertheless, the emerging 
evidence suggests that the α7 nAChRs may be important regulators of inflammation in both 
the central nervous system and the periphery [37]. The study by Wang et al. [38] established a 
link between the cholinergic activity of the vagus nerve and peripheral inflammation, with 
central involvement of α7 nAChRs expressed on macrophages. Electrical stimulation of the 
vagus nerve causes a significant decrease in tumor necrosis factor release from macrophages, 
and the effects of vagal stimulation were blocked by administration of α7 antagonists, and 
absent in α7 knockout mice. Shytle et al. [37] showed that exposure to acetylcholine or 
nicotine reduces inflammatory markers following the administration of lipopolysaccharide, 
and that this effect is blocked by α7 antagonists. Subsequent work established that vagus 
nerve signalling inhibits cytokine activities and improves disease endpoints in experimental 
models of IR, haemorrhagic shock, myocardial ischaemia and pancreatitis [39, 40, 41, 42]. 
Various immunologically competent cells (e.g. lymphocytes and microglia) express α7 
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AChR, so there is currently considerable interest in compounds that influence the function of 
the cholinergic anti-inflammatory pathway [43]. 
Our laboratory earlier reported that PC metabolites with an alcoholic moiety in the 
molecule (i.e. choline, N,N-dimethylethanolamine and N-methylethanolamine) inhibited ROS 
production both in vitro and in vivo, and displayed an effectiveness proportional to the 
number of methyl groups in the compounds. We furnished further evidence that PC 
metabolites may inhibit the formation of ROS by activated PMN leukocytes [44] (Ghyczy et 
al., 2008). 
In summary, the results presented here clearly show that exogenous GPC 
administration diminishes the multifactorial macro- and microcirculatory dysfunction, and 
reduces the ROS and RNS production and ATP depletion caused by an IR insult. In light of 
the above discussion, these data provide further, indirect evidence that the anti-inflammatory 
effects of PC may be linked to a reaction involving the polar part of the molecule. It is clear 
that additional investigations are required to analyse the mechanistic effects of GPC, but it is 
conceivable that GPC or GPC metabolites may be pivotal anti-inflammatory factors if present 
in the inflammatory milieu. 
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Figure captions 
Fig. 1 Mean arterial blood pressure changes during intestinal ischaemia-reperfusion (IR). The 
empty circles joined by a continuous line relate to the sham-operated group, grey triangles to 
the IR group, empty diamonds to the glycerylphosphorylcholine (GPC) pretreated group, and 
empty squares to the GPC post-treated group. Median values and 75th and 25th percentiles are 
given. *p < 0.05 relative to the baseline value (within groups); xp < 0.05 relative to the sham-
operated control group 
Fig. 2 Mesenteric vascular resistance changes during the experiments. The empty circles 
joined by a continuous line relate to the sham-operated group, grey triangles to the ischaemia-
reperfusion (IR) group, empty diamonds to the glycerylphosphorylcholine (GPC) pretreated 
group and empty squares to the GPC post-treated group. Median values and 75th and 25th 
percentiles are given. *p < 0.05 relative to the baseline value (within groups); xp < 0.05 
relative to the sham-operated control group 
Fig. 3 Superior mesenteric artery flow during the experiments. The empty circles joined by a 
continuous line relate to the sham-operated group, grey triangles to the ischaemia-reperfusion 
(IR) group, empty diamonds to the glycerylphosphorylcholine (GPC) pretreated group and 
empty squares to the GPC post-treated group. Median values and 75th and 25th percentiles are 
given. *p < 0.05 relative to the baseline value (within groups); xp < 0.05 relative to the sham-
operated control group 
Fig. 4 Red blood cell velocity changes during the experiment. The white box blot relates to 
the sham-operated group, the dark-grey box plot to the ischaemia-reperfusion (IR) group, the 
striped box plot to the glycerylphosphorylcholine (GPC) pretreated group and the checked 
box plot to the GPC post-treated group. Median values and 75th and 25th percentiles are given. 
*p < 0.05 relative to the baseline value (within groups); #p < 0.05 relative to the IR group  
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Fig. 5 Superoxide production in the small intestine. The white box blot relates to the sham-
operated group, the dark-grey box plot to the ischaemia-reperfusion (IR) group, the striped 
box plot to the glycerylphosphorylcholine (GPC) pretreated group and the checked box plot to 
the GPC post-treated group. Median values and 75th and 25th percentiles are given. *p < 0.05 
relative to the baseline value (within groups) 
Fig. 6 Xanthine oxidoreductase activity in the small intestine. The white box blot relates to 
the sham-operated group, the dark-grey box plot to the ischaemia-reperfusion (IR) group, the 
striped box plot to the glycerylphosphorylcholine (GPC) pretreated group and the checked 
box plot to the GPC post-treated group. Median values and 75th and 25th percentiles are given. 
xp < 0.05 relative to the sham-operated control group; #p < 0.05 relative to the IR group; @p < 
0.05 relative to the GPC pre-treated group 
Fig. 7 Nitrotyrosine level in the small intestine. The white box blot relates to the sham-
operated group, the dark-grey box plot to the ischaemia-reperfusion (IR) group, the striped 
box plot to the glycerylphosphorylcholine (GPC) pretreated group and the checked box plot to 
the GPC post-treated group. Median values and 75th and 25th percentiles are given. xp < 0.05 
relative to the sham-operated control group; #p < 0.05 relative to the IR group 
Fig. 8 ATP level in liver samples. The white box blot relates to the sham-operated group, the 
dark-grey box plot to the ischaemia-reperfusion (IR) group, the striped box plot to the 
glycerylphosphorylcholine (GPC) pretreated group and the checked box plot to the GPC post-
treated group. Median values and 75th and 25th percentiles are given. xp < 0.05 relative to the 
sham-operated control group; #p < 0.05 relative to the IR group 
 
